- TGA to “continue reviewing single-product telehealth prescribing”
- Report to Health Ministers in December
- Further nationally coordinated actions “may be required”
Australia’s Health Ministers met in Perth on Friday to discuss “health system reform priorities” including the National Health Reform Agreement and reforms to the National Registration and Accreditation Scheme.
For more, read our full article on the push for national reform here.
Under the heading ‘Cosmetic Injectables’, their formal communique noted the Ministers “discussed regulatory challenges in the cosmetic injectables sector, including inconsistent regulation, cross-border and telehealth workarounds, and non-compliant practices”.
They noted Ahpra’s new guidelines on “safe, ethical non-surgical cosmetic practice and nurse prescribing”.
The Commonwealth Department of Health, Disability and Ageing, including the Therapeutic Goods Administration, will “continue reviewing single-product telehealth prescribing and report to Health Ministers in December on any further nationally coordinated actions that may be required to ensure a patient-safety-focused regulatory environment”.
